H.B. Fuller (NYSE:FUL) Sets New 1-Year Low – What’s Next?

H.B. Fuller (NYSE:FUL)’s stock price reached a new 52-week low during trading on Friday . The stock traded as low as $52.15 and last traded at $51.69, with a volume of 41698 shares traded. The stock had previously closed at $54.34.

Analyst Ratings Changes

A number of research firms recently weighed in on FUL. Deutsche Bank Aktiengesellschaft lowered their target price on shares of H.B. Fuller from $75.00 to $72.00 and set a “buy” rating on the stock in a report on Wednesday, January 22nd. Citigroup dropped their target price on H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. JPMorgan Chase & Co. lowered their price target on H.B. Fuller from $60.00 to $50.00 and set an “underweight” rating for the company in a research report on Friday, March 28th. Vertical Research downgraded shares of H.B. Fuller from a “buy” rating to a “hold” rating in a report on Monday, January 6th. Finally, Seaport Res Ptn lowered shares of H.B. Fuller from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 5th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $63.33.

H.B. Fuller Trading Down 3.1 %

The firm has a fifty day moving average price of $57.65 and a 200-day moving average price of $67.82. The company has a market capitalization of $2.85 billion, a P/E ratio of 22.80, a price-to-earnings-growth ratio of 1.13 and a beta of 1.27. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.81 and a quick ratio of 1.16.

H.B. Fuller (NYSE:FUL) last announced its quarterly earnings data on Wednesday, March 26th. The specialty chemicals company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.49 by $0.05. The firm had revenue of $788.66 million during the quarter, compared to the consensus estimate of $769.55 million. H.B. Fuller had a return on equity of 12.01% and a net margin of 3.65%. The business’s revenue for the quarter was down 2.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.67 EPS. On average, equities research analysts anticipate that H.B. Fuller will post 4.07 earnings per share for the current year.

H.B. Fuller Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, February 20th. Shareholders of record on Thursday, February 6th were paid a $0.2225 dividend. This represents a $0.89 dividend on an annualized basis and a yield of 1.69%. The ex-dividend date of this dividend was Thursday, February 6th. H.B. Fuller’s payout ratio is 44.50%.

Insider Activity

In other news, CEO Celeste Beeks Mastin purchased 3,500 shares of the company’s stock in a transaction dated Tuesday, April 1st. The shares were purchased at an average price of $56.66 per share, with a total value of $198,310.00. Following the transaction, the chief executive officer now directly owns 3,500 shares of the company’s stock, valued at approximately $198,310. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.99% of the company’s stock.

Institutional Investors Weigh In On H.B. Fuller

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in FUL. Amundi increased its stake in shares of H.B. Fuller by 191.9% in the fourth quarter. Amundi now owns 28,553 shares of the specialty chemicals company’s stock worth $1,804,000 after purchasing an additional 18,771 shares in the last quarter. Lord Abbett & CO. LLC grew its stake in H.B. Fuller by 79.8% in the 3rd quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock valued at $57,952,000 after buying an additional 324,056 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in H.B. Fuller by 17.2% during the 4th quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company’s stock valued at $37,448,000 after acquiring an additional 81,558 shares during the period. Geode Capital Management LLC lifted its position in shares of H.B. Fuller by 1.5% during the third quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock worth $99,939,000 after acquiring an additional 18,734 shares in the last quarter. Finally, Jones Financial Companies Lllp boosted its holdings in shares of H.B. Fuller by 128.8% in the fourth quarter. Jones Financial Companies Lllp now owns 899 shares of the specialty chemicals company’s stock worth $61,000 after acquiring an additional 506 shares during the period. 95.93% of the stock is currently owned by institutional investors.

About H.B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.